Welcome to the New Era in Immune Health
Resetting the immune system. Reimagining treatment. Restoring balance for animals and people.
Our platform is revolutionizing immunotherapy.
Grounded in Nobel Prize-winning immune network theory, our platform technology AbstimX™ is designed to reset and rebalance the immune system. We’re building long-term therapies, not short-term fixes, for allergies, autoimmune conditions, and chronic inflammation in both humans and companion animals.
We're solving immune overactivity at the root.
Most current therapies manage inflammation by suppressing immune function. AbstimX™ takes a smarter approach: it re-trains the immune system to regulate itself, correcting dysfunction instead of masking it.
Who we are
Our team brings together experts in clinical medicine, veterinary therapeutics, biotech commercialization, and immunology research. With over 230 years of combined experience and 22 products brought to market, we know what it takes to translate science into scalable therapies.
Product Pipeline
First dogs, then humans
Why companion animals? Because immune dysfunction affects dogs just as it does people, and what works in dogs often works in humans.
NI-CAN-001: For canine allergies
Projected date: 2025*
Mode of application: Injectable (under the skin)
NI-CAN-002: For autoimmune disease in dogs
Projected date: 2026*
Mode of application: Injectable (under the skin)
NI-CAN-003: For colitis and digestive inflammation
Projected date: 2027*
Mode of application: Injectable (under the skin)
Looking towards the future
NI-HUM-001: A first-of-its-kind therapy for reducing human allergies
Mode of application: Injectable (under the skin)
Projected date: 2028*
NI-HUM-002: Designed for human autoimmune conditions
Projected date: 2028*
Mode of application: Injectable (under the skin)